FBIO
What one share of Fortress Biotech holds
Pharmaceutical Preparations
Fortress Biotech, Inc. (“Fortress” or the “Company”) is a biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holding and dividend and royalty revenue streams.
Fortress Biotech’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.15 |
|---|---|
| Profit | $3.25 |
| Cash and investments | $5.90 |
| Debt | $1.19 |
| Book value | $4.93 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $6.19 | −$20.68 | $2.39 | −$19.59 | — | $11.80 |
| 2017 | $6.21 | −$24.08 | $0.23 | −$29.51 | — | $15.47 |
| 2018 | $9.28 | −$29.04 | $2.44 | −$36.56 | — | $0.48 |
| 2019 | $10.04 | −$10.96 | $0.64 | −$26.68 | — | $5.31 |
| 2020 | $9.50 | −$9.69 | $0.40 | −$17.83 | — | $15.86 |
| 2021 | $12.63 | −$11.88 | $0.84 | −$22.23 | — | $16.07 |
| 2022 | $12.78 | −$15.97 | $0.46 | −$30.74 | — | $5.66 |
| 2023 | $10.42 | −$8.47 | $0.01 | −$15.82 | — | $1.49 |
| 2024 | $2.77 | −$2.69 | $0.00 | −$3.86 | — | $0.81 |
| 2025 | $2.27 | −$0.07 | — | −$2.36 | — | $1.59 |